Subject
Advanced and Specialized Nursing
Reference56 articles.
1. Further evidence that onabotulinum toxin is a viable treatment option for pediatric chronic migraine patients;Ali;Cureus,2019
2. Allergan. (2021). BOTOX (onabotulinumtoxinA): Pescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103000s5318lbl.pdf.
3. A qualitative study comparing physician-reported barriers to treating addiction using buprenorphine and extended-release naltrexone in U.S. office-based practices;Andraka-Christou;International Journal of Drug Policy,2018
4. The efficacy of botulinum toxin type-A for intractable chronic migraine patients with no pain-free time;Atraszkiewicz;British Journal of Pain,2022
5. OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial;Aurora;Cephalalgia,2010
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献